| Doctify | 60.0 | 7 | 0 |
| WATER'S EDGE DERMATOLOGY | 59.0 | 2 | 2 |
| Cosmetic Laser Dermatology | 48.9 | 2 | 1 |
| Skin Care and Laser Physicians of Beverly Hills | 48.9 | 2 | 1 |
| Gold Skin Care Center | 48.9 | 2 | 1 |
| Mayo Clinic | 46.4 | 4 | 0 |
| The Journal of clinical and aesthetic dermatology | 40.0 | 0 | 4 |
| American Medical Association | 40.0 | 3 | 0 |
| Bassett Healthcare Network | 40.0 | 3 | 0 |
| Skin Cancer Foundation | 37.2 | 1 | 1 |
| American Society for Dermatologic Surgery | 37.2 | 1 | 1 |
| Schweiger Dermatology Group (United States) | 37.2 | 1 | 1 |
| Facial skin rejuvenation: laser resurfacing or chemical peel: choose your weapon | 34.5 | 0 | 3 |
| Skin tightening effect using fractional laser treatment: I. A randomized half-side pilot study on faces of patients with acne | 34.5 | 0 | 3 |
| Skin tightening effect using fractional laser treatment II: A pilot animal study on skin remodeling | 34.5 | 0 | 3 |
| Lesion dimensions following ablative fractional laser treatment in non-melanoma skin cancer and premalignant lesions | 34.5 | 0 | 3 |
| Facial skin rejuvenation: Ablative laser resurfacing, chemical peels, or photodynamic therapy? Facts and controversies | 34.5 | 0 | 3 |
| Laser treatment of traumatic scars with an emphasis on ablative fractional laser resurfacing: consensus report | 34.5 | 0 | 3 |
| Evaluation of a new hyaluronic acid dermal filler for volume restoration | 34.5 | 0 | 3 |
| Polarization enhanced wide‐field imaging for evaluating dermal changes caused by non‐ablative fractional laser treatment | 34.5 | 0 | 3 |
| Chemical peels in aesthetic dermatology: an update 2009. | 34.5 | 0 | 3 |
| Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know | 34.5 | 0 | 3 |
| A Trial of Skin Care Protocols for Facial Resurfacing | 34.5 | 0 | 3 |
| World Patient Safety Day | 34.5 | 0 | 3 |
| Split-Sided Chest Study of Skin Rejuvenation Comparing Low-Energy, 1,927-nm Thulium Fractional Laser Treatment Prior to Photodynamic Therapy Versus Photodynamic Therapy Alone | 34.5 | 0 | 3 |
| Commentary on Retention Rates Among Patients Undergoing Multimodal Facial Rejuvenation Treatment Versus a Single Monotherapy in Cosmetic Dermatology Practices | 34.5 | 0 | 3 |
| Retention Rates Among Patients Undergoing Multimodal Facial Rejuvenation Treatment Versus a Single Monotherapy in Cosmetic Dermatology Practices | 34.5 | 0 | 3 |
| Stanford University | 31.7 | 2 | 0 |
| Massachusetts General Hospital | 31.7 | 2 | 0 |
| Cleveland Clinic | 31.7 | 2 | 0 |
| Duke University Health System | 31.7 | 2 | 0 |
| Texas Health Resources | 31.7 | 2 | 0 |
| University of Pittsburgh Medical Center | 31.7 | 2 | 0 |
| Wexner Medical Center at Ohio State University | 31.7 | 2 | 0 |
| HealthGrades | 31.7 | 2 | 0 |
| UCLA Health System | 31.7 | 2 | 0 |
| Nursing case management : managing the process of patient care | 31.7 | 2 | 0 |
| Cureus | 31.7 | 2 | 0 |
| Advanced Dermatology & Cosmetic Surgery | 31.7 | 2 | 0 |
| UPMC Health System | 31.7 | 2 | 0 |
| Laser and Skin Surgery Center of New York | 31.7 | 2 | 0 |
| Ohio State University Hospital | 31.7 | 2 | 0 |
| CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows | 31.7 | 2 | 0 |
| Johns Hopkins Medicine | 31.7 | 2 | 0 |
| South Eastern European Journal of Public Health | 31.7 | 2 | 0 |
| bidirectional encoder representations from transformers | 31.7 | 2 | 0 |
| Christopher R. Conley | 31.7 | 2 | 0 |
| Q96602914 | 31.7 | 2 | 0 |
| University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism | 31.7 | 2 | 0 |
| SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph | 31.7 | 2 | 0 |
| Bruce Scott | 31.7 | 2 | 0 |
| WebMD Magazine | 31.7 | 2 | 0 |
| skin care | 27.3 | 0 | 2 |
| La Roche-Posay | 27.3 | 0 | 2 |
| Mohs surgery | 27.3 | 0 | 2 |
| dermal fillers | 27.3 | 0 | 2 |
| Facial rejuvenation | 27.3 | 0 | 2 |
| National Institutes of Health Clinical Center | 27.3 | 0 | 2 |
| GoodLeap | 27.3 | 0 | 2 |
| Dermatologic Surgery | 27.3 | 0 | 2 |
| No7 product line | 27.3 | 0 | 2 |
| American College of Mohs Surgery | 27.3 | 0 | 2 |
| Patient factors influencing dermal filler complications: prevention, assessment, and treatment | 27.3 | 0 | 2 |
| The Journal of dermatologic surgery and oncology | 27.3 | 0 | 2 |
| Periorbital Phenol-Croton Oil Chemical Peel in Conjunction with Blepharoplasty: An Evolving Technique for Periorbital Facial Rejuvenation | 27.3 | 0 | 2 |
| Q28274622 | 27.3 | 0 | 2 |
| Long Island Skin Cancer and Dermatologic Surgery | 27.3 | 0 | 2 |
| The histologic evaluation of pulsed carbon dioxide laser resurfacing versus phenol chemical peels in vivo | 27.3 | 0 | 2 |
| A pilot study of in vivo immediate tissue contraction with CO2 skin laser resurfacing in a live farm pig. | 27.3 | 0 | 2 |
| Cutaneous side effects from laser treatment of the skin: skin cancer, scars, wounds, pigmentary changes, and purpura--use of pulsed dye laser, copper vapor laser, and argon laser | 27.3 | 0 | 2 |
| Fractional laser resurfacing for thermal burns. | 27.3 | 0 | 2 |
| A new option for skin rejuvenation: CO2-laser resurfacing | 27.3 | 0 | 2 |
| Skin laser treatments enhancing transdermal delivery of ALA. | 27.3 | 0 | 2 |
| Evaluation of combined fractional radiofrequency and fractional laser treatment for acne scars in Asians | 27.3 | 0 | 2 |
| Analysis of the temporal change in biophysical parameters after fractional laser treatments using reflectance confocal microscopy. | 27.3 | 0 | 2 |
| Cervicoplasty and facial laser resurfacing: a paired technique for facial rejuvenation | 27.3 | 0 | 2 |
| Long-term results of facial rejuvenation by carbon dioxide laser resurfacing using a quantitative method of assessment | 27.3 | 0 | 2 |
| Improving skin care through data: a pitch for patient safety incident reporting. | 27.3 | 0 | 2 |
| Bilateral scleral thermal injury: complication after skin laser resurfacing | 27.3 | 0 | 2 |
| Laser peel: facial rejuvenation with a superficial erbium:YAG laser treatment | 27.3 | 0 | 2 |
| Preoperative and postoperative skin care with laser resurfacing | 27.3 | 0 | 2 |
| A case report of laser resurfacing as a skin cancer prophylaxis | 27.3 | 0 | 2 |
| Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer | 27.3 | 0 | 2 |
| Guidelines for the management of squamous cell carcinoma in organ transplant recipients | 27.3 | 0 | 2 |
| New classification scheme for laser resurfacing and chemical peels: modifications for the different ethnic groups | 27.3 | 0 | 2 |
| The lamellar peel: a sequential nonablative and ablative laser treatment for facial skin rejuvenation | 27.3 | 0 | 2 |
| Fractional Laser treatment for pigmentation and texture improvement. | 27.3 | 0 | 2 |
| Incorporating photodynamic therapy into a medical and cosmetic dermatology practice | 27.3 | 0 | 2 |
| Ablative fractional laser resurfacing for the treatment of a third-degree burn. | 27.3 | 0 | 2 |
| Treatment of Poikiloderma of Civatte with ablative fractional laser resurfacing: prospective study and review of the literature. | 27.3 | 0 | 2 |
| What's new in aesthetic dermatology: filler and laser treatments | 27.3 | 0 | 2 |
| Nonablative fractional laser resurfacing | 27.3 | 0 | 2 |
| Fractional laser resurfacing: why all the fuss? | 27.3 | 0 | 2 |
| Comparison of clinical outcome parameters, the Patient Benefit Index (PBI‐k) and patient satisfaction after ablative fractional laser treatment of peri‐orbital rhytides | 27.3 | 0 | 2 |
| Connective tissue response to fractionated thermo-ablative Erbium: YAG skin laser treatment | 27.3 | 0 | 2 |
| Application of fractional laser resurfacing in the treatment of superficial scar | 27.3 | 0 | 2 |
| Ablative laser resurfacing: is it still the gold standard for facial rejuvenation? | 27.3 | 0 | 2 |
| Fractional ablative carbon dioxide laser resurfacing for skin rejuvenation and acne scars in Asians | 27.3 | 0 | 2 |
| A European evaluation of cosmetic treatment of facial volume loss with Juvéderm™ Voluma™ in patients previously treated with Restylane Sub-Q™. | 27.3 | 0 | 2 |
| Nonablative fractional laser resurfacing in Asian skin--a review | 27.3 | 0 | 2 |
| A retrospective analysis of the management of acne post-inflammatory hyperpigmentation using topical treatment, laser treatment, or combination topical and laser treatments in oriental patients | 27.3 | 0 | 2 |
| Commentary: Autologous Platelet-Rich Plasma with Fractional Laser Resurfacing | 27.3 | 0 | 2 |
| Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients | 27.3 | 0 | 2 |
| Issues in the delivery of dermatologic surgery for skin cancer | 27.3 | 0 | 2 |
| A two-temperature model for selective photothermolysis laser treatment of port wine stains | 27.3 | 0 | 2 |
| A simple intervention to reinforce awareness of tanning bed use and skin cancer in non‐medical skin care professionals in Southern California | 27.3 | 0 | 2 |
| The role of vascular endothelial growth factor in fractional laser resurfacing with the carbon dioxide laser | 27.3 | 0 | 2 |
| Knowledge, understanding, and use of preventive strategies against nonmelanoma skin cancer in healthy and immunosuppressed individuals undergoing Mohs surgery | 27.3 | 0 | 2 |
| The need for evidence-based aesthetic dermatology practice | 27.3 | 0 | 2 |
| Functional Improvement After Ablative Fractional Laser Treatment of a Scar Contracture | 27.3 | 0 | 2 |
| Fractional laser resurfacing of acne scarring in patients with Fitzpatrick skin types IV-VI | 27.3 | 0 | 2 |
| Platelet-Rich Plasma Combined with Fractional Laser Therapy for Skin Rejuvenation | 27.3 | 0 | 2 |
| Fractional laser resurfacing for acne scars: a review | 27.3 | 0 | 2 |
| Multicenter clinical trial of a home-use nonablative fractional laser device for wrinkle reduction | 27.3 | 0 | 2 |
| Nonablative fractional laser resurfacing for the treatment of scars and grafts after Mohs micrographic surgery: a randomized controlled trial | 27.3 | 0 | 2 |
| Commentary: Can 1927-nm thulium fractional laser treatment truly remove seborrheic keratoses? | 27.3 | 0 | 2 |
| Commentary: Fractional Laser Resurfacing to Enhance Skin Permeation | 27.3 | 0 | 2 |
| Skin tightening induced by fractional CO(2) laser treatment: quantified assessment of variations in mechanical properties of the skin | 27.3 | 0 | 2 |
| Non-ablative 1540 fractional laser: how far could it help injection lipolysis and dermal fillers in lower-face rejuvenation? A randomized controlled trial. | 27.3 | 0 | 2 |
| Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: an objective evaluation. | 27.3 | 0 | 2 |
| Skin Cancer Epidemiology, Detection, and Management | 27.3 | 0 | 2 |
| Nonablative Fractional Laser Resurfacing for the Treatment of Hypertrophic Scars: A Randomized Controlled Trial | 27.3 | 0 | 2 |
| Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing : optimization of the applied dose for postoperative care | 27.3 | 0 | 2 |
| Ablative fractional laser treatment for hypertrophic scars: comparison between Er:YAG and CO2 fractional lasers. | 27.3 | 0 | 2 |
| A retrospective chart review to assess the safety of nonablative fractional laser resurfacing in Fitzpatrick skin types IV to VI | 27.3 | 0 | 2 |
| The role of transforming growth factor β1 in fractional laser resurfacing with a carbon dioxide laser | 27.3 | 0 | 2 |
| Minimizing skin cancer surgical scars using ablative fractional Er:YAG laser treatment | 27.3 | 0 | 2 |
| A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up | 27.3 | 0 | 2 |
| A new lightening approach to acne treatment-combining therapy modalities for maximizing acne treatment: Phototherapy (LHE™), drugs, skin rejuvenation and skin tightening | 27.3 | 0 | 2 |
| Lux1540nm fractional laser treatment for superficial scar | 27.3 | 0 | 2 |
| Monitoring of wound healing process of human skin after fractional laser treatments with optical coherence tomography. | 27.3 | 0 | 2 |
| In vivo non-invasive monitoring of collagen remodelling by two-photon microscopy after micro-ablative fractional laser resurfacing. | 27.3 | 0 | 2 |
| Treatment of acne scars and wrinkles in asian patients using carbon-dioxide fractional laser resurfacing: its effects on skin biophysical profiles | 27.3 | 0 | 2 |
| Non‐ablative fractional laser provides long‐term improvement of mature burn scars–A randomized controlled trial with histological assessment | 27.3 | 0 | 2 |
| Ablative Fractional Laser Resurfacing Helps Treat Restrictive Pediatric Scar Contractures | 27.3 | 0 | 2 |
| Comparison of non-ablative and ablative fractional laser treatments in a postoperative scar study | 27.3 | 0 | 2 |
| Erbium:yttrium aluminum garnet ablative laser resurfacing for skin tightening | 27.3 | 0 | 2 |
| Fractional nonablative laser resurfacing: is there a skin tightening effect? | 27.3 | 0 | 2 |
| Long pulsed 1064 nm Nd:YAG laser treatment for wrinkle reduction and skin laxity: evaluation of new parameters | 27.3 | 0 | 2 |
| Bacterial infections following non‐ablative fractional laser treatment: A case series and discussion | 27.3 | 0 | 2 |
| 1064 nm long‐pulsed Nd:YAG laser treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Ablative Fractional Laser Resurfacing for Abdominal Scar Contractures in Pregnancy | 27.3 | 0 | 2 |
| Laser treatment of solar lentigines on dorsum of hands: QS Ruby laser versus ablative CO2 fractional laser – a randomized controlled trial | 27.3 | 0 | 2 |
| Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods | 27.3 | 0 | 2 |
| Hair regrowth through wound healing process after ablative fractional laser treatment in a murine model. | 27.3 | 0 | 2 |
| Development of the facial skin care index: a health-related outcomes index for skin cancer patients | 27.3 | 0 | 2 |
| Patient safety in dermatologic surgery: Part I. Safety related to surgical procedures | 27.3 | 0 | 2 |
| Current Status of Fractional Laser Resurfacing | 27.3 | 0 | 2 |
| Healing of chronic wounds with adjunctive ablative fractional laser resurfacing in two pediatric patients | 27.3 | 0 | 2 |
| Intense pulsed light, near infrared pulsed light, and fractional laser combination therapy for skin rejuvenation in Asian subjects: a prospective multi-center study in China | 27.3 | 0 | 2 |
| Ablative fractional laser resurfacing with topical paromomycin as adjunctive treatment for a recalcitrant cutaneous leishmaniasis wound | 27.3 | 0 | 2 |
| Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice | 27.3 | 0 | 2 |
| Nonablative Fractional Laser Resurfacing for Acne Scarring in Patients With Fitzpatrick Skin Phototypes IV-VI. | 27.3 | 0 | 2 |
| Fractional non-ablative laser treatment at 1410 nm wavelength for periorbital wrinkles – reviscometrical and clinical evaluation | 27.3 | 0 | 2 |
| Investigation of optical attenuation imaging using optical coherence tomography for monitoring of scars undergoing fractional laser treatment. | 27.3 | 0 | 2 |
| Nonablative fractional laser treatment for the skin in the eye area - clinical and cutometric analysis | 27.3 | 0 | 2 |
| Noninvasive Facial Rejuvenation. Part 3: Physician-Directed-Lasers, Chemical Peels, and Other Noninvasive Modalities | 27.3 | 0 | 2 |
| Combination of microneedle radiofrequency (RF), fractional RF skin resurfacing and multi-source non-ablative skin tightening for minimal-downtime, full-face skin rejuvenation | 27.3 | 0 | 2 |
| Polydeoxyribonucleotide improves wound healing of fractional laser resurfacing in rat model | 27.3 | 0 | 2 |
| Comparison of the Effectiveness of Ablative and Non-Ablative Fractional Laser Treatments for Early Stage Thyroidectomy Scars | 27.3 | 0 | 2 |
| Effect of Methyl Aminolevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: A Randomized Clinical Trial | 27.3 | 0 | 2 |
| Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey | 27.3 | 0 | 2 |
| Calcium Hydroxylapatite Dermal Filler for Treatment of Dorsal Hand Volume Loss: Results From a 12-Month, Multicenter, Randomized, Blinded Trial | 27.3 | 0 | 2 |
| Patient safety's missing link: using clinical expertise to recognize, respond to and reduce risks at a population level | 27.3 | 0 | 2 |
| Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. | 27.3 | 0 | 2 |
| A peeler's thoughts on skin improvement with chemical peels and laser resurfacing. | 27.3 | 0 | 2 |
| Skin Cancer in the Crosshairs: Highlights from the Biennial Scientific Retreat of International Transplant Skin Cancer Collaborative and Skin Care in Organ Transplant Recipients Europe | 27.3 | 0 | 2 |
| Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations | 27.3 | 0 | 2 |
| Dermal fillers and combinations of fillers for facial rejuvenation | 27.3 | 0 | 2 |
| Viral oncogenesis and its role in nonmelanoma skin cancer | 27.3 | 0 | 2 |
| AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for M | 27.3 | 0 | 2 |
| Facial rejuvenation starts in the midface: three‐dimensional volumetric facial rejuvenation has beneficial effects on nontreated neighboring esthetic units | 27.3 | 0 | 2 |
| Topical Treatment of Basal Cell Carcinoma with the Immune Response Modifier Imiquimod | 27.3 | 0 | 2 |
| Reconstruction of Large Facial Defects after Delayed Mohs Surgery for Skin Cancer | 27.3 | 0 | 2 |
| Second-intention healing of exposed facial-scalp bone after Mohs surgery for skin cancer: review of ninety-one cases. | 27.3 | 0 | 2 |
| Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an outreach skin care program | 27.3 | 0 | 2 |
| Ablative Fractional Laser Resurfacing With Laser-Assisted Delivery of 5-Fluorouracil for the Treatment of Cicatricial Ectropion and Periocular Scarring. | 27.3 | 0 | 2 |
| Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee | 27.3 | 0 | 2 |
| Dermatologic surgery practice and skin cancer treatment in Canada: results of a national survey | 27.3 | 0 | 2 |
| Comparison of a series of superficial chemical peels with a single midlevel chemical peel for the correction of facial actinic damage | 27.3 | 0 | 2 |
| Racial differences in skin cancer awareness and surveillance practices at a public hospital dermatology clinic | 27.3 | 0 | 2 |
| Identifying and defining complications of dermatologic surgery to be tracked in the American College of Mohs Surgery (ACMS) Registry | 27.3 | 0 | 2 |
| The Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Dermal Filler for Treatment of Nasolabial Folds: A Multicenter, Randomized Clinical Study | 27.3 | 0 | 2 |
| Costs and Economics of Skin Cancer Management, Mohs Surgery, and Surgical Reconstruction | 27.3 | 0 | 2 |
| Redefining Dermatologists' Role in Skin Cancer Early Detection and Follow-up Care. | 27.3 | 0 | 2 |
| Facelift combined with simultaneous fractional laser resurfacing: Outcomes and complications | 27.3 | 0 | 2 |
| Nonablative Fractional Laser Resurfacing in Skin of Color: Evidence-based Review | 27.3 | 0 | 2 |
| Nasal Valve Dysfunction after Mohs Surgery for Skin Cancer of the Nose | 27.3 | 0 | 2 |
| Topical Brimonidine Gel as a Hemostatic Agent After Dermatologic Surgery | 27.3 | 0 | 2 |
| Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer | 27.3 | 0 | 2 |
| Rapid development of nonmelanoma skin cancer after CO2 laser resurfacing | 27.3 | 0 | 2 |
| Mohs surgery in the treatment of skin cancer. | 27.3 | 0 | 2 |
| Recent Advances in Fractional Laser Resurfacing: New Paradigm in Optimal Parameters and Post-Treatment Wound Care | 27.3 | 0 | 2 |
| A novel, multistep, combination facial rejuvenation procedure for treatment of the whole face with incobotulinumtoxinA, and two dermal fillers- calcium hydroxylapatite and a monophasic, polydensified hyaluronic acid filler | 27.3 | 0 | 2 |
| Medical error in dermatology practice: Development of a classification system to drive priority setting in patient safety efforts | 27.3 | 0 | 2 |
| Office based dermatological surgery and Mohs surgery: A prospective audit of surgical procedures and complications in a procedural dermatology practice | 27.3 | 0 | 2 |
| Mortality after dermatologic surgery for nonmelanoma skin cancer in patients aged 80 years and older | 27.3 | 0 | 2 |
| Chemical peels in aesthetic dermatology | 27.3 | 0 | 2 |
| The frequency of body dysmorphic disorder in dermatology and cosmetic dermatology clinics: a study from Turkey | 27.3 | 0 | 2 |
| Ablative fractional laser resurfacing: A powerful tool to help restore form and function during international medical exchange | 27.3 | 0 | 2 |
| Facial Volume Restoration with Permanent Dermal Filler (Artecoll-4) in Chinese Women | 27.3 | 0 | 2 |
| Laser-assisted drug delivery: Enhanced response to ingenol mebutate after ablative fractional laser treatment | 27.3 | 0 | 2 |
| Treatment of Segmental Keratosis Follicularis (Darier Disease) Using Ablative Fractional Laser Resurfacing | 27.3 | 0 | 2 |
| Introduction to Dermatologic Surgery Special Issue on Skin Tightening | 27.3 | 0 | 2 |
| How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer | 27.3 | 0 | 2 |
| Nail debridement after ablative fractional laser treatment and occlusive dressing with urea 20% cream: An alternative to nail extraction. | 27.3 | 0 | 2 |
| Evaluation of nonablative fractional laser treatment in scar reduction | 27.3 | 0 | 2 |
| Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer. | 27.3 | 0 | 2 |
| Perioperative effects of oral midazolam premedication in children undergoing skin laser treatment. A double-blinded randomized placebo-controlled trial. | 27.3 | 0 | 2 |
| What's up dermatology? A pilot survey of the use of WhatsApp in dermatology practice and case discussion among members of WhatsApp dermatology groups. | 27.3 | 0 | 2 |
| Patient safety considerations regarding dermal filler injections | 27.3 | 0 | 2 |
| Understanding the anatomy when using dermal fillers enhances patient safety | 27.3 | 0 | 2 |
| Advances in fractional technology for skin rejuvenation, skin tightening, drug delivery, and treating scars and skin defects | 27.3 | 0 | 2 |
| Benefits of volumetric to facial rejuvenation. Part 2: Dermal fillers | 27.3 | 0 | 2 |
| Body experience and self-esteem after minimally invasive skin rejuvenation : Study of female patients using botulinum toxin A and/or dermal fillers | 27.3 | 0 | 2 |
| Re: "How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer". | 27.3 | 0 | 2 |
| Physician Survey Regarding Patient Nonattendance at Follow-up Appointments at a University-Affiliated Medical Dermatology Clinic | 27.3 | 0 | 2 |
| The Accuracy of Measurements of Nonmelanoma Skin Cancer Sizes Referred to the Mohs Surgery Clinic | 27.3 | 0 | 2 |
| A Split-Face Assessment of the Synergistic Potential of Sequential Q-Switched Nd:YAG Laser and 1565 nm Fractional Nonablative Laser Treatment for Facial Rejuvenation in Fitzpatrick Skin Type II-V Patients | 27.3 | 0 | 2 |
| Scalp Cyst Excision in an Unknown Previous Site of Neurosurgery: Issues in Patient Safety in Dermatologic Surgery | 27.3 | 0 | 2 |
| Multicenter, Randomized, Parallel-Group Study of the Safety and Effectiveness of OnabotulinumtoxinA and Hyaluronic Acid Dermal Fillers (24-mg/mL Smooth, Cohesive Gel) Alone and in Combination for Lower Facial Rejuvenation | 27.3 | 0 | 2 |
| Multicenter, Randomized, Parallel-Group Study of OnabotulinumtoxinA and Hyaluronic Acid Dermal Fillers (24-mg/mL Smooth, Cohesive Gel) Alone and in Combination for Lower Facial Rejuvenation: Satisfaction and Patient-Reported Outcomes | 27.3 | 0 | 2 |
| The comparison of skin rejuvenation effects of vitamin A, fractional laser, and their combination on rat. | 27.3 | 0 | 2 |
| Ablative Fractional Laser Resurfacing: A Promising Adjunct to Surgical Reconstruction | 27.3 | 0 | 2 |
| Skin rejuvenation and wrinkle reduction using a fractional radiofrequency system. | 27.3 | 0 | 2 |
| Use of AccuVein™ for preventing complications from accidental venipuncture when administering dermal filler injections | 27.3 | 0 | 2 |
| Rapid healing after skin laser resurfacing: a minimal mechanical trauma technique. | 27.3 | 0 | 2 |
| Reply to: “Laser assisted drug delivery: Enhanced response to ingenol mebutate after ablative fractional laser treatment” | 27.3 | 0 | 2 |
| A Predictive Model for Primary Closure Lengths in Mohs Surgery Based on Skin Cancer Type, Dimensions, and Location | 27.3 | 0 | 2 |
| Laser treatments in early wound healing improve scar appearance: a randomized split-wound trial with nonablative fractional laser exposures vs. untreated controls | 27.3 | 0 | 2 |
| Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative | 27.3 | 0 | 2 |
| Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin | 27.3 | 0 | 2 |
| Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project | 27.3 | 0 | 2 |
| Safety, Effectiveness and Subject Satisfaction Study of a Dermal Filler ( of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face | 27.3 | 0 | 2 |
| Chemical Peels and Fractional Laser on IGF-1 Levels in Skin | 27.3 | 0 | 2 |
| Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation | 27.3 | 0 | 2 |
| Early Non-Ablative Fractional Laser Resurfacing for Acne Scars After Treatment With Oral Isotretinoin | 27.3 | 0 | 2 |
| Investigating the Wrinkle Reduction Potential of a Novel Compounded Skin Care Cream | 27.3 | 0 | 2 |
| Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers | 27.3 | 0 | 2 |
| Laser Resurfacing Versus Dermabrasion for Scar Revision | 27.3 | 0 | 2 |
| Post Treatment Care After Chemical Peel or Laser Resurfacing | 27.3 | 0 | 2 |
| Non Ablative Fractional Laser Treatment of Burn Scars | 27.3 | 0 | 2 |
| Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis | 27.3 | 0 | 2 |
| Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease | 27.3 | 0 | 2 |
| 10 600 nm Ablative Fractional Laser Treatment of Scars: a Prospective Single Blinded Within Patient Controlled Randomized Trial | 27.3 | 0 | 2 |
| Pan Facial Volume Restoration | 27.3 | 0 | 2 |
| 1540nm Non Ablative Fractional Laser Treatment of Scars | 27.3 | 0 | 2 |
| Comparison of Outcome Parameters in Laser Rhytide Treatment | 27.3 | 0 | 2 |
| Sequential facial skin rejuvenation with intense pulsed light and non-ablative fractionated laser resurfacing in fitzpatrick skin type II-IV patients: A prospective multicenter analysis | 27.3 | 0 | 2 |
| A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics | 27.3 | 0 | 2 |
| Volume Restoration of Plantar Pad With a Hyaluronic Acid Dermal Filler in Metatarsalgia | 27.3 | 0 | 2 |
| Clinical Efficacy of Bovine Freeze-dried Amniotic Membrane on Wound Healing in Laser Treatment | 27.3 | 0 | 2 |
| Assessment of Needs of Moisturizers After Various Laser Treatments | 27.3 | 0 | 2 |
| Safety and Efficacy Study for Various Skin Conditions | 27.3 | 0 | 2 |
| Histological Study to Evaluate Skin Changes After PicoWay® 1064 nm and 532nm Picosecond Fractional Laser Treatment | 27.3 | 0 | 2 |
| Efficacy of AFL-assisted PDT in Microinvasive Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence | 27.3 | 0 | 2 |
| Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause | 27.3 | 0 | 2 |
| Electronic Brachytherapy (eBx)-Mohs Matched Pair - Cohort Study A Multi-Center Retrospective-Prospective Matched Pairs Cohort Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx Compared to Non-melan | 27.3 | 0 | 2 |
| Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures | 27.3 | 0 | 2 |
| Buddy Relationships in DermatoloGic Excisions for Skin Cancer | 27.3 | 0 | 2 |
| [The dermatophytic flora surveyed at the Dermatology Clinic of the Tottori University Hospital from 1981 to 1984--statistic analysis of the patients of various clinical types and a comparative study of the ratios of T. rubrum/T. mentagrophytes at de | 27.3 | 0 | 2 |
| Skin care, chemical face peeling, and skin rejuvenation | 27.3 | 0 | 2 |
| Laser resurfacing and facial rejuvenation | 27.3 | 0 | 2 |
| The Effect of Additional Laser Treatments. | 27.3 | 0 | 2 |
| Open, Non-Comparative Study To Evaluate The Performance Of The Medical Device JANESSE® | 27.3 | 0 | 2 |
| MD Auralia (HA Filler) in Treatment of Nasolabial Wrinkles | 27.3 | 0 | 2 |
| Observations on skin cancer in the Zwickau skin clinic | 27.3 | 0 | 2 |
| Cosmetic dermatology and skin care | 27.3 | 0 | 2 |
| The impact of cosmetic dermatology on skin care and cosmetics | 27.3 | 0 | 2 |
| Botox injections for lower facial rejuvenation | 27.3 | 0 | 2 |
| Fractional laser resurfacing | 27.3 | 0 | 2 |
| Advances in facial rejuvenation: Botulinum toxin A. Hyaluronic acid dermal fillers, and combination therapies--consensus recomendations. Editor's Foreword | 27.3 | 0 | 2 |
| Core curriculum for plastic surgical nursing: nonsurgical skin rejuvenation: chemical peels and microdermabrasion | 27.3 | 0 | 2 |
| Fractional laser resurfacing | 27.3 | 0 | 2 |
| Fate of medical dermatology in the era of cosmetic dermatology and dermatosurgery | 27.3 | 0 | 2 |
| Prognosis of pretransplant melanoma | 27.3 | 0 | 2 |
| Melanoma in solid organ transplant recipients | 27.3 | 0 | 2 |
| Evidence for fractional laser treatment in the improvement of cutaneous scars | 27.3 | 0 | 2 |
| Combined fractional laser treatment with 1550-nm erbium glass and 10 600-nm carbon dioxide lasers | 27.3 | 0 | 2 |
| The Pelleve Procedure: an Effective Method for Facial Wrinkle Reduction and Skin Tightening | 27.3 | 0 | 2 |
| What can you tell me about Mohs surgery for skin cancer? | 27.3 | 0 | 2 |
| Facing skin cancer surgery. Mohs surgery may be your best option for nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Skin cancer screening campaigns in a Bucharest Dermatology Clinic | 27.3 | 0 | 2 |
| Teaching Cosmetic Dermatology Without Sacrificing the Proper Emphasis on Medical Dermatology | 27.3 | 0 | 2 |
| Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study | 27.3 | 0 | 2 |
| Intralesional Laser Treatment for Dermal Filler Complications | 27.3 | 0 | 2 |
| Promotion of wound healing through low-fluence ablative fractional laser treatment in diabetic mice | 27.3 | 0 | 2 |
| Fractional Laser Resurfacing Treats Photoaging by Promoting Neocollegenesis and Cutaneous Edema | 27.3 | 0 | 2 |
| Fall risk assessment and injury prevention in the Mohs surgery clinic: a review of the literature and recommendations for improving patient safety | 27.3 | 0 | 2 |
| Novel Use of Non-Invasive Devices and Microbiopsies to Assess Facial Skin Rejuvenation Following Laser Treatment | 27.3 | 0 | 2 |
| Change in Sun-Protective Behavior After Dermatologic Surgery for Skin Cancer in High-Risk Patients | 27.3 | 0 | 2 |
| Correction of cicatricial ectropion using non-ablative fractional laser resurfacing | 27.3 | 0 | 2 |
| Digital ex-vivo confocal imaging for fast Mohs surgery in nonmelanoma skin cancers: An emerging technique in dermatologic surgery | 27.3 | 0 | 2 |
| Skin cancer in transplant recipients: Scientific retreat of the international immunosuppression and transplant skin cancer collaborative and skin care in organ transplant patients-Europe | 27.3 | 0 | 2 |
| Ablative Fractional Laser Resurfacing: A Novel Treatment for Hypergranulation Tissue | 27.3 | 0 | 2 |
| Efficacy of 1,550-nm Erbium-Glass Fractional Laser Treatment and Its Effect on the Expression of Insulin-Like Growth Factor 1 and Wnt/β-Catenin in Androgenetic Alopecia | 27.3 | 0 | 2 |
| Pathomorphological criteria of use efficiency of resorbable and permanent implants in aesthetic medicine and cosmetic dermatology | 27.3 | 0 | 2 |
| Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes | 27.3 | 0 | 2 |
| Combination chemical peels are more effective than single chemical peel in treatment of mild-to-moderate acne vulgaris: A split face comparative clinical trial | 27.3 | 0 | 2 |
| Nonablative and Hybrid Fractional Laser Skin Rejuvenation | 27.3 | 0 | 2 |
| Prescription Skin Care Products and Skin Rejuvenation | 27.3 | 0 | 2 |
| Renuvion/J-Plasma for Subdermal Skin Tightening Facial Contouring and Skin Rejuvenation of the Face and Neck | 27.3 | 0 | 2 |
| Beyond the physician's perspective: A review of patient-reported outcomes in dermatologic surgery and cosmetic dermatology | 27.3 | 0 | 2 |
| Erbium fractional laser irradiation combined with autologous platelet-rich plasma and platelet-poor plasma application for facial rejuvenation | 27.3 | 0 | 2 |
| Assessment of the efficacy and safety of platelet poor plasma gel as autologous dermal filler for facial rejuvenation | 27.3 | 0 | 2 |
| Optimizing Patient Safety in Dermatologic Surgery | 27.3 | 0 | 2 |
| Amy Forman Taub | 27.3 | 0 | 2 |
| Chemical Peels in Skin Cancer: A Review | 27.3 | 0 | 2 |
| 12-month Prospective Study of Polymethylmethacrylate/Collagen Dermal Filler for Volume Loss of the Dorsal of Hands | 27.3 | 0 | 2 |
| The 308-nm excimer laser treatment does not increase the risk of skin cancer in patients with vitiligo: A population-based retrospective cohort study | 27.3 | 0 | 2 |
| Molluscum Contagiosum Infection After 1927-nm Nonablative Fractional Laser Treatment | 27.3 | 0 | 2 |
| Chemical Peels: Role of Chemical Peels in Facial Rejuvenation Today | 27.3 | 0 | 2 |
| Ablative fractional laser resurfacing for treatment of sclerosis and contractures in chronic graft-versus-host disease: A pilot study | 27.3 | 0 | 2 |
| Fractional microneedling radiofrequency and fractional 1927 nm thulium laser treatment offer synergistic skin rejuvenation: A pilot case series | 27.3 | 0 | 2 |
| The Outcome of Early Ablative Fractional Laser Treatment for Thyroidectomy Scars | 27.3 | 0 | 2 |
| A cosmetic treatment based on the secretion of Cryptomphalus aspersa 40% improves the clinical results after the use of nonablative fractional laser in skin aging | 27.3 | 0 | 2 |
| Picosecond-Domain Fractional Laser Treatment Over Hyaluronic Acid Fillers: In Vivo and Clinical Studies | 27.3 | 0 | 2 |
| Renuvion RF-Helium Plasma for Subdermal Skin Tightening, Facial Contouring and Skin Rejuvenation of the Face and Neck | 27.3 | 0 | 2 |
| An Analysis of Biopsies for Suspected Skin Cancer at a Tertiary Care Dermatology Clinic in the Western Cape Province of South Africa | 27.3 | 0 | 2 |
| Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer | 27.3 | 0 | 2 |
| Mohs Surgery for the Treatment of Skin Cancer: A Review of Guidelines | 27.3 | 0 | 2 |
| Fractional Radiofrequency Microneedling Combined With Fractional Carbon Dioxide Laser Treatment for Striae Distensae | 27.3 | 0 | 2 |
| Smoothbeam laser treatment may help improve hidradenitis suppurativa but not Hailey-Hailey disease | 27.3 | 0 | 2 |
| Facial plastic surgery & aesthetic medicine | 27.3 | 0 | 2 |
| Sustained improvement of surgical scar appearance one year after early intervention with nonablative fractional laser treatment: a randomized controlled split-wound trial | 27.3 | 0 | 2 |
| Bundled intervention to improve patient safety by reducing skin specimen related errors in a tertiary dermatology practice | 27.3 | 0 | 2 |
| The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment | 27.3 | 0 | 2 |
| Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face | 27.3 | 0 | 2 |
| CD4+/CD8+ T-Cell Ratio Predictive of Surgical Margins in the Treatment of Nonmelanoma Skin Cancer Treated With Mohs Surgery of Patients Infected With the Human Immunodeficiency Virus | 27.3 | 0 | 2 |
| Attitudes on Prophylactic Antibiotic Use in Dermatologic Surgery: A Survey Study of American College of Mohs Surgery Members | 27.3 | 0 | 2 |
| The Effectiveness of Early Combined CO2 Ablative Fractional Laser and 595-nm Pulsed Dye Laser Treatment After Scar Revision | 27.3 | 0 | 2 |
| Cosmetic Dermatology-An Often-Overlooked Tool for Medical Dermatology | 27.3 | 0 | 2 |
| Ablative fractional laser treatment of hypertrophic burn and traumatic scars: a systematic review of the literature | 27.3 | 0 | 2 |
| Laser Treatment for Non-Melanoma Skin Cancer: A Systematic Review and Meta-Analysis | 27.3 | 0 | 2 |
| Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling | 27.3 | 0 | 2 |
| Recognizing and Managing Complications in Laser Resurfacing, Chemical Peels, and Dermabrasion | 27.3 | 0 | 2 |
| Administration of skin care regimens containing β-glucan for skin recovery after fractional laser therapy: A split-face, double-blinded, vehicle-controlled study | 27.3 | 0 | 2 |
| Erratum: Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer | 27.3 | 0 | 2 |
| Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy | 27.3 | 0 | 2 |
| Value of volume restoration procedures with dermal filler in the mid-face | 27.3 | 0 | 2 |
| Laser Treatment for the Improvement of Scars and Scleroderma | 27.3 | 0 | 2 |
| Transcriptomic analysis of human skin wound healing and rejuvenation following ablative fractional laser treatment | 27.3 | 0 | 2 |
| LB1107 Enhancing cosmesis while achieving stellar cure rates for early stage non-melanoma skin cancer in the outpatient dermatology clinic using a novel non-invasive modality | 27.3 | 0 | 2 |
| Simultaneous Combination Treatment Using High-Intensity Focused Ultrasound and Fractional Carbon Dioxide Laser Resurfacing for Facial Rejuvenation | 27.3 | 0 | 2 |
| Ablative fractional laser treatment reduces hedgehog pathway gene expression in murine basal cell carcinomas | 27.3 | 0 | 2 |
| Fractional laser resurfacing for acne scars: Our experience at tertiary care hospital of North India | 27.3 | 0 | 2 |
| Using dermal fillers for vaginal skin rejuvenation | 27.3 | 0 | 2 |
| Spacest.com | 27.3 | 0 | 2 |
| Nour Alhuda Odeh | 27.3 | 0 | 2 |
| Dr. Busso Cosmetic Dermatology | 27.3 | 0 | 2 |
| Q137043408 | 27.3 | 0 | 2 |
| LeVogue Med Spa | 27.3 | 0 | 2 |
| Botox and Fillers by Dr. Catalina Henao | 27.3 | 0 | 2 |
| Siam Dermatology | 27.3 | 0 | 2 |
| Clínica Hexsel de Dermatologia | 27.3 | 0 | 2 |
| Solas Health & Wellness | 27.3 | 0 | 2 |
| Greenwich Medical Spa | 27.3 | 0 | 2 |
| Gerhard Casper | 20.0 | 1 | 0 |
| arXiv | 20.0 | 1 | 0 |
| The Zoological Record | 20.0 | 1 | 0 |
| Laboratoires Expanscience | 20.0 | 1 | 0 |
| Allure | 20.0 | 1 | 0 |
| Allergan, Inc. | 20.0 | 1 | 0 |
| Johns Hopkins School of Medicine | 20.0 | 1 | 0 |
| Allergan plc | 20.0 | 1 | 0 |
| Pennsylvania Hospital | 20.0 | 1 | 0 |
| Keith Devlin | 20.0 | 1 | 0 |
| Johns Hopkins Hospital | 20.0 | 1 | 0 |
| Mount Sinai Hospital | 20.0 | 1 | 0 |
| Ovid Technologies | 20.0 | 1 | 0 |
| polymyalgia rheumatica | 20.0 | 1 | 0 |
| UCLA Ronald Reagan Medical Center | 20.0 | 1 | 0 |
| Mayo Clinic Hospital — Rochester | 20.0 | 1 | 0 |
| Current Opinion in Anesthesiology | 20.0 | 1 | 0 |
| Brigham and Women's Hospital | 20.0 | 1 | 0 |
| Molecular Endocrinology | 20.0 | 1 | 0 |
| WebMD | 20.0 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 20.0 | 1 | 0 |
| American Academy of Dermatology | 20.0 | 1 | 0 |
| American Medical News | 20.0 | 1 | 0 |
| American Society of Plastic Surgeons | 20.0 | 1 | 0 |
| Q4769463 | 20.0 | 1 | 0 |
| Arthur L. Jenkins | 20.0 | 1 | 0 |
| Corinne Goldsmith Dickinson Center for Multiple Sclerosis | 20.0 | 1 | 0 |
| Hoover Tower | 20.0 | 1 | 0 |
| Hospital of the University of Pennsylvania | 20.0 | 1 | 0 |
| Howard County General Hospital | 20.0 | 1 | 0 |
| Johnnie B. Byrd, Sr. Alzheimer's Center & Research Institute | 20.0 | 1 | 0 |
| Journal of Educational Psychology | 20.0 | 1 | 0 |
| Journal of Obstetric, Gynecologic, & Neonatal Nursing | 20.0 | 1 | 0 |
| UCLA Jules Stein Eye Institute | 20.0 | 1 | 0 |
| Les Earnest | 20.0 | 1 | 0 |
| Ann & Robert H. Lurie Children's Hospital of Chicago | 20.0 | 1 | 0 |
| Mayo Clinic Hospital – Jacksonville | 20.0 | 1 | 0 |
| Mayo School of Health Sciences | 20.0 | 1 | 0 |
| Mitchel P. Goldman | 20.0 | 1 | 0 |
| NYU Langone Health | 20.0 | 1 | 0 |
| Neurogrid | 20.0 | 1 | 0 |
| Obstetrics and Gynecology | 20.0 | 1 | 0 |
| Mass General Brigham | 20.0 | 1 | 0 |
| Paul DeMarinis | 20.0 | 1 | 0 |
| PayScale | 20.0 | 1 | 0 |
| Penn Presbyterian Medical Center | 20.0 | 1 | 0 |
| Perelman Center for Advanced Medicine | 20.0 | 1 | 0 |
| Presbyterian Hospital of Dallas | 20.0 | 1 | 0 |
| Refinery29 | 20.0 | 1 | 0 |
| Richard M. Ross Heart Hospital | 20.0 | 1 | 0 |
| Robert E. Horn | 20.0 | 1 | 0 |
| Scheie Eye Institute | 20.0 | 1 | 0 |
| Scripps Mercy Hospital | 20.0 | 1 | 0 |
| Scripps Health | 20.0 | 1 | 0 |
| Sibley Memorial Hospital | 20.0 | 1 | 0 |
| SkinCeuticals | 20.0 | 1 | 0 |
| Sofia Frangou | 20.0 | 1 | 0 |
| Stanford Hospital and Clinics | 20.0 | 1 | 0 |
| Stanford Taiko | 20.0 | 1 | 0 |
| Stanford University Medical Center | 20.0 | 1 | 0 |
| TeachAIDS | 20.0 | 1 | 0 |
| The Journal of Allergy and Clinical Immunology | 20.0 | 1 | 0 |
| UCLA Santa Monica Medical Center | 20.0 | 1 | 0 |
| UCSF Medical Center | 20.0 | 1 | 0 |
| UPMC Hamot | 20.0 | 1 | 0 |
| UPMC Mercy | 20.0 | 1 | 0 |
| UPMC Mercy South Side Outpatient Center | 20.0 | 1 | 0 |
| UPMC St. Margaret | 20.0 | 1 | 0 |
| Michigan Medicine | 20.0 | 1 | 0 |
| University of Pennsylvania Health System | 20.0 | 1 | 0 |
| University of South Florida College of Medicine | 20.0 | 1 | 0 |
| University of South Florida College of Nursing | 20.0 | 1 | 0 |
| University of South Florida College of Public Health | 20.0 | 1 | 0 |
| University of Virginia Health System | 20.0 | 1 | 0 |
| Victor Velculescu | 20.0 | 1 | 0 |
| Zocdoc | 20.0 | 1 | 0 |
| Current Opinion in Otolaryngology & Head and Neck Surgery | 20.0 | 1 | 0 |
| Michael Saunders | 20.0 | 1 | 0 |
| Johns Hopkins Bayview Medical Center | 20.0 | 1 | 0 |
| Current Opinion in Infectious Diseases | 20.0 | 1 | 0 |
| Current Opinion in Rheumatology | 20.0 | 1 | 0 |
| Nursing Administration Quarterly | 20.0 | 1 | 0 |
| Advances in Nursing Science | 20.0 | 1 | 0 |
| Current Opinion in Nephrology and Hypertension | 20.0 | 1 | 0 |
| Current Opinion in Ophthalmology | 20.0 | 1 | 0 |
| Holistic Nursing Practice | 20.0 | 1 | 0 |
| Journal of Nursing Administration | 20.0 | 1 | 0 |
| Current Opinion in Obstetrics and Gynecology | 20.0 | 1 | 0 |
| Nick McKeown | 20.0 | 1 | 0 |
| Stephen P. Boyd | 20.0 | 1 | 0 |
| Q16117390 | 20.0 | 1 | 0 |
| Healthline | 20.0 | 1 | 0 |
| Suburban Hospital | 20.0 | 1 | 0 |
| Dr. Nathan Davis Awards | 20.0 | 1 | 0 |
| Edward Thomas Ryan | 20.0 | 1 | 0 |
| Dermstore | 20.0 | 1 | 0 |
| Robert Y. Moore | 20.0 | 1 | 0 |
| Manu Prakash | 20.0 | 1 | 0 |
| William G. Nelson | 20.0 | 1 | 0 |
| RealSelf | 20.0 | 1 | 0 |
| Charles Limb | 20.0 | 1 | 0 |
| Joseph John Klimek | 20.0 | 1 | 0 |
| Melina R. Uncapher | 20.0 | 1 | 0 |
| Mayo Clinic Graduate School of Biomedical Sciences | 20.0 | 1 | 0 |
| Brent L. Hughes | 20.0 | 1 | 0 |
| Current opinion in organ transplantation | 20.0 | 1 | 0 |
| JOGN nursing; journal of obstetric, gynecologic, and neonatal nursing | 20.0 | 1 | 0 |
| Outcomes management for nursing practice | 20.0 | 1 | 0 |
| The virtual mentor : VM | 20.0 | 1 | 0 |
| Sidney Kimmel Comprehensive Cancer Center | 20.0 | 1 | 0 |
| Minh-Thang Luong | 20.0 | 1 | 0 |
| Scripps Whittier Diabetes Institute | 20.0 | 1 | 0 |
| UPMC Montefiore | 20.0 | 1 | 0 |
| UPMC Magee-Womens Hospital | 20.0 | 1 | 0 |
| Washington Institute of Dermatologic Laser Surgery | 20.0 | 1 | 0 |
| UPMC Presbyterian | 20.0 | 1 | 0 |
| Scripps Green Hospital | 20.0 | 1 | 0 |
| Mayo Clinic Hospital | 20.0 | 1 | 0 |
| A. Alfred Taubman Health Care Center | 20.0 | 1 | 0 |
| Forefront of Dermatology | 20.0 | 1 | 0 |
| Dermatology Specialists | 20.0 | 1 | 0 |
| Sadick Dermatology | 20.0 | 1 | 0 |
| Duke University Medical Center | 20.0 | 1 | 0 |
| Duke Children's Hospital & Health Center | 20.0 | 1 | 0 |
| Scripps Clinic Medical Group | 20.0 | 1 | 0 |
| Scripps Memorial Hospital | 20.0 | 1 | 0 |
| Shadyside Hospital | 20.0 | 1 | 0 |
| Mattel Children's Hospital | 20.0 | 1 | 0 |
| Women's Hospital | 20.0 | 1 | 0 |
| Harvard Affiliated Emergency Medicine Residency | 20.0 | 1 | 0 |
| Scripps Clinic | 20.0 | 1 | 0 |
| Jameson Memorial Hospital | 20.0 | 1 | 0 |
| University of Virginia Hospital | 20.0 | 1 | 0 |
| UPMC McKeesport | 20.0 | 1 | 0 |
| WCA Hospital | 20.0 | 1 | 0 |
| American Society for Laser Medicine and Surgery | 20.0 | 1 | 0 |
| Dermatology Foundation | 20.0 | 1 | 0 |
| U.S. News & World Report Best Hospitals Rankings | 20.0 | 1 | 0 |
| Karl Herxheimer | 17.2 | 0 | 1 |
| melanoma | 17.2 | 0 | 1 |
| skin cancer | 17.2 | 0 | 1 |
| Clearasil | 17.2 | 0 | 1 |
| Nadine Dorries | 17.2 | 0 | 1 |
| German Coalition for Patient Safety | 17.2 | 0 | 1 |
| equine sarcoid | 17.2 | 0 | 1 |
| mesotherapy | 17.2 | 0 | 1 |
| basal-cell carcinoma of the skin | 17.2 | 0 | 1 |
| toner | 17.2 | 0 | 1 |
| exfoliation | 17.2 | 0 | 1 |
| pedicure | 17.2 | 0 | 1 |
| The Helsinki Declaration for Patient Safety in Anaesthesiology | 17.2 | 0 | 1 |
| intense pulsed light | 17.2 | 0 | 1 |
| Endovenous laser treatment | 17.2 | 0 | 1 |
| reticle | 17.2 | 0 | 1 |
| cleanser | 17.2 | 0 | 1 |
| High 5s Project | 17.2 | 0 | 1 |
| Revlon | 17.2 | 0 | 1 |
| patient safety | 17.2 | 0 | 1 |
| Q1477309 | 17.2 | 0 | 1 |
| International Society for Dermatologic Surgery | 17.2 | 0 | 1 |
| Merkel cell carcinoma | 17.2 | 0 | 1 |
| photobiomodulation | 17.2 | 0 | 1 |
| Jamie King | 17.2 | 0 | 1 |
| sari cancer | 17.2 | 0 | 1 |
| liquid bandage | 17.2 | 0 | 1 |
| Biotherm | 17.2 | 0 | 1 |
| kangaroo care | 17.2 | 0 | 1 |
| facial | 17.2 | 0 | 1 |
| Artistry | 17.2 | 0 | 1 |
| Fitzpatrick scale | 17.2 | 0 | 1 |
| chemical peel | 17.2 | 0 | 1 |
| aesthetic medicine | 17.2 | 0 | 1 |
| Category:Skin cancer | 17.2 | 0 | 1 |
| NARS Cosmetics | 17.2 | 0 | 1 |
| R. Rox Anderson | 17.2 | 0 | 1 |
| EBooking | 17.2 | 0 | 1 |
| Tweaking | 17.2 | 0 | 1 |
| Aesop | 17.2 | 0 | 1 |
| Aquaphor | 17.2 | 0 | 1 |
| Aveeno | 17.2 | 0 | 1 |
| Photorejuvenation | 17.2 | 0 | 1 |
| Bronner Bros. | 17.2 | 0 | 1 |
| Cetaphil | 17.2 | 0 | 1 |
| Clarisonic | 17.2 | 0 | 1 |
| anti-aging cream | 17.2 | 0 | 1 |
| Drug, Healthcare and Patient Safety | 17.2 | 0 | 1 |
| elementary key normal form | 17.2 | 0 | 1 |
| Ella Baché | 17.2 | 0 | 1 |
| Etix | 17.2 | 0 | 1 |
| Fraxel | 17.2 | 0 | 1 |
| Freederm | 17.2 | 0 | 1 |
| Gold Bond | 17.2 | 0 | 1 |
| cutaneous squamous-cell carcinoma | 17.2 | 0 | 1 |
| list of EMS provider credentials | 17.2 | 0 | 1 |
| list of cutaneous conditions associated with increased risk of nonmelanoma skin cancer | 17.2 | 0 | 1 |
| Lucian Leape | 17.2 | 0 | 1 |
| Medical device connectivity | 17.2 | 0 | 1 |
| National Patient Safety Agency | 17.2 | 0 | 1 |
| National Patient Safety Foundation | 17.2 | 0 | 1 |
| Natural skin care | 17.2 | 0 | 1 |
| Category:Patient safety | 17.2 | 0 | 1 |
| Patient Safety and Quality Improvement Act | 17.2 | 0 | 1 |
| Patient safety organization | 17.2 | 0 | 1 |
| Category:Deaths from skin cancer | 17.2 | 0 | 1 |
| Preetika Rao | 17.2 | 0 | 1 |
| Saudi Society of Dermatology and Dermatologic Surgery | 17.2 | 0 | 1 |
| Platelet-rich fibrin matrix | 17.2 | 0 | 1 |
| Category:Skin care | 17.2 | 0 | 1 |
| Skin Cancer: Recognition and Management | 17.2 | 0 | 1 |
| skin cancer in cats and dogs | 17.2 | 0 | 1 |
| Trabeculoplasty | 17.2 | 0 | 1 |
| Category:Dermatologic surgery | 17.2 | 0 | 1 |
| Category:Skin cancer survivors | 17.2 | 0 | 1 |
| Solanka Park in Inowrocław | 17.2 | 0 | 1 |
| Patient Safety Act (2010:659) | 17.2 | 0 | 1 |
| Template:Skin tumors, nevi and melanomas | 17.2 | 0 | 1 |
| OXY | 17.2 | 0 | 1 |
| day spa | 17.2 | 0 | 1 |
| Hada Labo | 17.2 | 0 | 1 |
| Cidesco | 17.2 | 0 | 1 |
| Category:Aesthetic medicine | 17.2 | 0 | 1 |
| Lisa Vanderpump | 17.2 | 0 | 1 |
| Patient Safety in Surgery | 17.2 | 0 | 1 |
| Journal of Cosmetic Dermatology | 17.2 | 0 | 1 |
| Pechoin | 17.2 | 0 | 1 |
| International Association for Physicians in Aesthetic Medicine | 17.2 | 0 | 1 |
| Berenson the Robot | 17.2 | 0 | 1 |
| Keogh Review | 17.2 | 0 | 1 |
| ClickBus | 17.2 | 0 | 1 |
| Rachel K | 17.2 | 0 | 1 |
| Gene therapy trial for skin cancer cures two terminal patients | 17.2 | 0 | 1 |
| GolfNow | 17.2 | 0 | 1 |
| Pennsylvania Patient Safety Authority | 17.2 | 0 | 1 |
| FromAtoB.com | 17.2 | 0 | 1 |
| Johnson's Baby | 17.2 | 0 | 1 |
| skin carcinoma | 17.2 | 0 | 1 |
| skin carcinoma in situ | 17.2 | 0 | 1 |
| Zoe Foster Blake | 17.2 | 0 | 1 |
| Maria Caulfield | 17.2 | 0 | 1 |
| Scottish Patient Safety Programme | 17.2 | 0 | 1 |
| Dermal filler | 17.2 | 0 | 1 |
| Skin care | 17.2 | 0 | 1 |
| ABO Blood Group and Incidence of Skin Cancer | 17.2 | 0 | 1 |
| Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety | 17.2 | 0 | 1 |
| Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study | 17.2 | 0 | 1 |
| Danish Patient Safety Authority | 17.2 | 0 | 1 |
| Skin cancer in Australia | 17.2 | 0 | 1 |
| Nonmelanoma Skin Cancer | 17.2 | 0 | 1 |
| Epidemiology and Economic Burden of Nonmelanoma Skin Cancer | 17.2 | 0 | 1 |
| Untreated Depression and Hippocampal Volume Loss | 17.2 | 0 | 1 |
| Diviac | 17.2 | 0 | 1 |
| Kaya Limited | 17.2 | 0 | 1 |
| Aveeno Baby product line | 17.2 | 0 | 1 |
| CeraVe | 17.2 | 0 | 1 |
| EOS Products, LLC | 17.2 | 0 | 1 |
| James Titcombe | 17.2 | 0 | 1 |
| A case-control study of skin cancer in the tire and rubber manufacturing industry | 17.2 | 0 | 1 |
| Comparison of Florida skin cancer screening rates with those in different US regions | 17.2 | 0 | 1 |
| Teens teach skin cancer prevention | 17.2 | 0 | 1 |
| Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer | 17.2 | 0 | 1 |
| Self-reported dermatitis and skin cancer in California farm operators | 17.2 | 0 | 1 |
| Skin cancer prevention and detection practices in a Michigan farm population following an educational intervention | 17.2 | 0 | 1 |
| Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms | 17.2 | 0 | 1 |
| Frontline Hospital Workers and the Worker Safety/Patient Safety Nexus | 17.2 | 0 | 1 |
| Joint Commission Journal on Quality and Patient Safety | 17.2 | 0 | 1 |
| Workplace Safety Equals Patient Safety | 17.2 | 0 | 1 |
| Reported skin cancer screening of US adult workers | 17.2 | 0 | 1 |
| Skin cancer epidemiological studies | 17.2 | 0 | 1 |
| Laser resurfacing for facial acne scars | 17.2 | 0 | 1 |
| Laser treatment of drusen to prevent progression to advanced age-related macular degeneration | 17.2 | 0 | 1 |
| Educational programmes for primary prevention of skin cancer | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Educational programmes for skin cancer prevention | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Laser treatment of drusen to prevent progression to advanced age-related macular degeneration | 17.2 | 0 | 1 |
| Chlorhexidine skin care for the prevention of infection in term neonates | 17.2 | 0 | 1 |
| Educational programmes for skin cancer prevention | 17.2 | 0 | 1 |
| Laser treatment of drusen to prevent progression to advanced age-related macular degeneration | 17.2 | 0 | 1 |
| Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer | 17.2 | 0 | 1 |
| Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi | 17.2 | 0 | 1 |
| Anaesthesiology as a model for patient safety in health care | 17.2 | 0 | 1 |
| David Westfall Bates, MD: a conversation with the editor on improving patient safety, quality of care, and outcomes by using information technology. Interview by William Clifford Roberts | 17.2 | 0 | 1 |
| A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q23 | 17.2 | 0 | 1 |
| Excimer laser treatment for high and extreme myopia | 17.2 | 0 | 1 |
| Federal patient safety initiatives panel summary | 17.2 | 0 | 1 |
| The Role of Manganese Superoxide Dismutase in Skin Cancer | 17.2 | 0 | 1 |
| A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris | 17.2 | 0 | 1 |
| Population-Based Inorganic Mercury Biomonitoring and the Identification of Skin Care Products as a Source of Exposure in New York City | 17.2 | 0 | 1 |
| Hospitalized patients' participation and its impact on quality of care and patient safety | 17.2 | 0 | 1 |
| Nonsurgical innovations in the treatment of nonmelanoma skin cancer | 17.2 | 0 | 1 |
| Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis | 17.2 | 0 | 1 |
| Patient safety and error management: what causes adverse events and how can they be prevented? | 17.2 | 0 | 1 |
| Indocyanine green enhanced near‐infrared laser treatment of murine mammary carcinoma | 17.2 | 0 | 1 |
| Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians | 17.2 | 0 | 1 |
| Work system design for patient safety: the SEIPS model | 17.2 | 0 | 1 |
| IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer | 17.2 | 0 | 1 |
| Realistic expectations of prepulse inhibition in translational models for schizophrenia research | 17.2 | 0 | 1 |
| Patient participation: current knowledge and applicability to patient safety | 17.2 | 0 | 1 |
| Suppressor role of activating transcription factor 2 (ATF2) in skin cancer | 17.2 | 0 | 1 |
| Grape seed proanthocyanidines and skin cancer prevention: inhibition of oxidative stress and protection of immune system | 17.2 | 0 | 1 |
| A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions | 17.2 | 0 | 1 |
| Tropic Skin Care | 17.2 | 0 | 1 |
| Emergency department overcrowding in the United States: an emerging threat to patient safety and public health | 17.2 | 0 | 1 |
| Quest for quality care and patient safety: the case of Singapore | 17.2 | 0 | 1 |
| Differential role of basal keratinocytes in UV-induced immunosuppression and skin cancer | 17.2 | 0 | 1 |
| Improving patient safety in hospitals: Contributions of high-reliability theory and normal accident theory | 17.2 | 0 | 1 |
| Patient safety in surgery | 17.2 | 0 | 1 |
| Patient safety features of clinical computer systems: questionnaire survey of GP views | 17.2 | 0 | 1 |
| Workplace Violence Prevention: Improving Front-Line Health-Care Worker and Patient Safety | 17.2 | 0 | 1 |
| Utility of patient safety case finding methods and associations among organizational safety climate, nurse injuries, and errors | 17.2 | 0 | 1 |
| Pro/antioxidant status in murine skin following topical exposure to cumene hydroperoxide throughout the ontogeny of skin cancer | 17.2 | 0 | 1 |
| Sunlight and Skin Cancer | 17.2 | 0 | 1 |
| Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study | 17.2 | 0 | 1 |
| A Model for UV-Induction of Skin Cancer | 17.2 | 0 | 1 |
| Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study | 17.2 | 0 | 1 |
| A model community skin cancer prevention project in Maine | 17.2 | 0 | 1 |
| Follow-up care by patient's own general practitioner after contact with out-of-hours care. A descriptive study | 17.2 | 0 | 1 |
| Digital diagnosis: new tool for detecting skin cancer | 17.2 | 0 | 1 |
| Chemical assessment of "In-Use" allergic contact dermatitis patch test reagents from dermatology clinics | 17.2 | 0 | 1 |
| Radio Frequency skin tightening | 17.2 | 0 | 1 |
| Using evidence-based community and behavioral interventions to prevent skin cancer: opportunities and challenges for public health practice. | 17.2 | 0 | 1 |
| Identifying feed and seed stores as a site to promote skin cancer control: a social marketing approach to agricultural health communication | 17.2 | 0 | 1 |
| Insect antimicrobial peptides: potential tools for the prevention of skin cancer | 17.2 | 0 | 1 |
| Optimal delivery of follow-up care after surgery for Crohn's disease: current perspectives | 17.2 | 0 | 1 |
| Disruption of Vitamin D and Calcium Signaling in Keratinocytes Predisposes to Skin Cancer | 17.2 | 0 | 1 |
| Photoaging and the clinical utility of fractional laser | 17.2 | 0 | 1 |
| The Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin Cancer | 17.2 | 0 | 1 |
| Circadian Dysrhythmias, Physiological Aberrations, and the Link to Skin Cancer | 17.2 | 0 | 1 |
| Nucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer Therapy | 17.2 | 0 | 1 |
| Clinical and Biological Principles of Cold Atmospheric Plasma Application in Skin Cancer | 17.2 | 0 | 1 |
| Potential Benefits of Omega-3 Fatty Acids in Non-Melanoma Skin Cancer | 17.2 | 0 | 1 |
| Improving Patient Safety through Simulation Training in Anesthesiology: Where Are We? | 17.2 | 0 | 1 |
| Optimizing Quality of Care and Patient Safety in Malaysia: The Current Global Initiatives, Gaps and Suggested Solutions | 17.2 | 0 | 1 |
| Brachytherapy in the treatment of skin cancer: an overview | 17.2 | 0 | 1 |
| Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy | 17.2 | 0 | 1 |
| Optimal delivery of male breast cancer follow-up care: improving outcomes | 17.2 | 0 | 1 |
| Brachytherapy in non melanoma skin cancer of eyelid: a systematic review | 17.2 | 0 | 1 |
| The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors | 17.2 | 0 | 1 |
| Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer | 17.2 | 0 | 1 |
| Sun-related behaviors among individuals previously diagnosed with non-melanoma skin cancer | 17.2 | 0 | 1 |
| Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer | 17.2 | 0 | 1 |
| Psychometric properties of the Nursing Home Survey on Patient Safety Culture in Norwegian nursing homes | 17.2 | 0 | 1 |
| Assessing Improvement of Facial Appearance and Quality of Life after Minimally-Invasive Cosmetic Dermatology Procedures Using the FACE-Q Scales | 17.2 | 0 | 1 |
| Standardizing the Early Identification of Acute Kidney Injury: The NHS England National Patient Safety Alert | 17.2 | 0 | 1 |
| Dhoti cancer: a waistline skin cancer with review of literature | 17.2 | 0 | 1 |
| Development of Facial Rejuvenation Procedures: Thirty Years of Clinical Experience with Face Lifts | 17.2 | 0 | 1 |
| The Tricky Tear Trough: A Review of Topical Cosmeceuticals for Periorbital Skin Rejuvenation | 17.2 | 0 | 1 |
| Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines | 17.2 | 0 | 1 |
| A research agenda on patient safety in primary care. Recommendations by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| First experiences with patient safety initiatives in Greek rural primary care. Action research by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Patient safety initiatives in Central and Eastern Europe: A mixed methods approach by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Involving patients in patient safety programmes: A scoping review and consensus procedure by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Patient safety improvement programmes for primary care. Review of a Delphi procedure and pilot studies by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Patient safety and the control of time in primary care: A review of the French tempos framework by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| A safety incident reporting system for primary care. A systematic literature review and consensus procedure by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Developing a patient safety incident classification system for primary care. A literature review and Delphi-survey by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Quality indicators for patient safety in primary care. A review and Delphi-survey by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Measurement tools and process indicators of patient safety culture in primary care. A mixed methods study by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Good practice statements on safe laboratory testing: A mixed methods study by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Improving medication safety in primary care. A review and consensus procedure by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Reducing diagnostic errors in primary care. A systematic meta-review of computerized diagnostic decision support systems by the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| Developing a research agenda for patient safety in primary care. Background, aims and output of the LINNEAUS collaboration on patient safety in primary care | 17.2 | 0 | 1 |
| The effects of laser treatment in tendinopathy: a systematic review | 17.2 | 0 | 1 |
| Multimorbidity and Patient Safety Incidents in Primary Care: A Systematic Review and Meta-Analysis | 17.2 | 0 | 1 |
| Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation | 17.2 | 0 | 1 |
| Endoscopic botox injections in therapy of refractory gastroparesis | 17.2 | 0 | 1 |
| Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair | 17.2 | 0 | 1 |
| Skin care: Historical and contemporary views | 17.2 | 0 | 1 |
| Harnessing implementation science to improve care quality and patient safety: a systematic review of targeted literature | 17.2 | 0 | 1 |
| Journal of Skin Cancer | 17.2 | 0 | 1 |
| Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer? | 17.2 | 0 | 1 |
| Choosing a GP, breast cancer, patient safety, and online dating | 17.2 | 0 | 1 |
| Classifying Health Information Technology patient safety related incidents – an approach used in Wales | 17.2 | 0 | 1 |
| The mechanistic basis of arsenicosis: pathogenesis of skin cancer | 17.2 | 0 | 1 |
| Health IT and Patient Safety: Building Safer Systems for Better Care | 17.2 | 0 | 1 |
| Risks to patient safety associated with implementation of electronic applications for medication management in ambulatory care - a systematic review | 17.2 | 0 | 1 |
| Lessons learned from dental patient safety case reports | 17.2 | 0 | 1 |
| Just culture: a foundation for balanced accountability and patient safety | 17.2 | 0 | 1 |
| Unfavourable results in facial rejuvenation surgery: How to avoid them | 17.2 | 0 | 1 |
| The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection | 17.2 | 0 | 1 |
| A systematic review of worldwide incidence of nonmelanoma skin cancer | 17.2 | 0 | 1 |
| The role of the EP receptors for prostaglandin E2 in skin and skin cancer | 17.2 | 0 | 1 |
| Long-term breast cancer patient follow-up care | 17.2 | 0 | 1 |
| The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives | 17.2 | 0 | 1 |
| Nanoscale biofunctionalization of polymer surfaces by laser treatment for controlled cellular differentiation | 17.2 | 0 | 1 |
| Skin Cancer Prevention among School Children: a Brief Review | 17.2 | 0 | 1 |
| UV-induced occupational skin cancer: possibilities of secondary individual prevention in the "Dermatologist's Procedure" | 17.2 | 0 | 1 |
| Drug Reaction, Skin Care, Skin Loss | 17.2 | 0 | 1 |
| Cervicofacial subcutaneous emphysema associated with dental laser treatment | 17.2 | 0 | 1 |
| Rapid-response systems as a patient safety strategy: a systematic review | 17.2 | 0 | 1 |
| Laser treatment of port-wine stains | 17.2 | 0 | 1 |
| Patient safety and minimizing risk with insulin administration – role of insulin degludec | 17.2 | 0 | 1 |
| Use of radiofrequency in cosmetic dermatology: focus on nonablative treatment of acne scars | 17.2 | 0 | 1 |
| Cellular reprogramming in skin cancer | 17.2 | 0 | 1 |
| First, do less harm : confronting the inconvenient problems of patient safety | 17.2 | 0 | 1 |
| Promoting a culture of safety as a patient safety strategy: a systematic review | 17.2 | 0 | 1 |
| Large molecular systems landscape uncovers T cell trapping in human skin cancer | 17.2 | 0 | 1 |
| Automated Video Analysis of Non-verbal Communication in a Medical Setting. | 17.2 | 0 | 1 |
| Integrating teamwork, clinician occupational well-being and patient safety - development of a conceptual framework based on a systematic review | 17.2 | 0 | 1 |
| Perceived versus Observed Patient Safety Measures in a Critical Care Unit from a Teaching Hospital in Southern Colombia | 17.2 | 0 | 1 |
| Image Statistics and the Fine Lines of Material Perception | 17.2 | 0 | 1 |
| The Learning Objective Catalogue for Patient Safety in Undergraduate Medical Education--A Position Statement of the Committee for Patient Safety and Error Management of the German Association for Medical Education | 17.2 | 0 | 1 |
| Standard chemoradiation for glioblastoma results in progressive brain volume loss | 17.2 | 0 | 1 |
| From Science to Service: A Framework for the Transfer of Patient Safety Research into Practice | 17.2 | 0 | 1 |
| The Journal of dermatologic surgery | 17.2 | 0 | 1 |
| Journal of patient safety | 17.2 | 0 | 1 |
| Medical laser application : international journal for laser treatment and research | 17.2 | 0 | 1 |
| Associations among rotating night shift work, sleep and skin cancer in Nurses' Health Study II participants | 17.2 | 0 | 1 |
| Detection of skin cancer by classification of Raman spectra | 17.2 | 0 | 1 |
| Photodynamic Therapy and Non-Melanoma Skin Cancer | 17.2 | 0 | 1 |
| Skin Cancer Prevention (PDQ®): Health Professional Version | 17.2 | 0 | 1 |
| 3D-printing techniques in a medical setting: a systematic literature review | 17.2 | 0 | 1 |
| Skin Cancer Screening (PDQ®): Health Professional Version | 17.2 | 0 | 1 |
| Skin Cancer Prevention (PDQ®): Patient Version | 17.2 | 0 | 1 |
| Skin Cancer Treatment (PDQ®): Patient Version | 17.2 | 0 | 1 |
| Patient Safety in Ambulatory Settings [Internet] | 17.2 | 0 | 1 |
| The Danish Nonmelanoma Skin Cancer Dermatology Database | 17.2 | 0 | 1 |
| A first step toward understanding patient safety | 17.2 | 0 | 1 |
| Genetics of Skin Cancer (PDQ®): Health Professional Version | 17.2 | 0 | 1 |
| Improving the governance of patient safety in emergency care: a systematic review of interventions | 17.2 | 0 | 1 |
| Characterising the nature of primary care patient safety incident reports in the England and Wales National Reporting and Learning System: a mixed-methods agenda-setting study for general practice | 17.2 | 0 | 1 |
| Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature | 17.2 | 0 | 1 |
| Skin Cancer Treatment (PDQ®): Health Professional Version | 17.2 | 0 | 1 |
| Follow-up care for survivors of lymphoma who have received curative-intent treatment | 17.2 | 0 | 1 |
| Improving patient safety through the involvement of patients: development and evaluation of novel interventions to engage patients in preventing patient safety incidents and protecting them against unintended harm | 17.2 | 0 | 1 |
| Needlestick and Sharps Injuries in Dermatologic Surgery: A Review of Preventative Techniques and Post-exposure Protocols | 17.2 | 0 | 1 |
| Prediction of the Occurrence of Melanoma and Non-melanoma Skin Cancer in Patients with Vitiligo | 17.2 | 0 | 1 |
| Delinking resident duty hours from patient safety | 17.2 | 0 | 1 |
| Recent developments in laser treatment of diabetic retinopathy | 17.2 | 0 | 1 |
| A Comparison of Inpatient Glucose Management Guidelines: Implications for Patient Safety and Quality | 17.2 | 0 | 1 |
| Year in Review 2014: Patient Safety | 17.2 | 0 | 1 |
| Noninvasive skin tightening: focus on new ultrasound techniques | 17.2 | 0 | 1 |
| Gaps in the continuity of care and progress on patient safety | 17.2 | 0 | 1 |
| Neonatal skin care: the scientific basis for practice | 17.2 | 0 | 1 |
| Cosmetics and skin care products. A historical perspective | 17.2 | 0 | 1 |
| Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer | 17.2 | 0 | 1 |
| HLA-G in skin cancer: a wolf in sheep's clothing? | 17.2 | 0 | 1 |
| Dietary supplements in the setting of mohs surgery | 17.2 | 0 | 1 |
| Improving patient safety using interactive, evidence-based decision support tools | 17.2 | 0 | 1 |
| Skin care management: educational aspects | 17.2 | 0 | 1 |
| Emblica cascading antioxidant: a novel natural skin care ingredient | 17.2 | 0 | 1 |
| Role of vitamins in skin care | 17.2 | 0 | 1 |
| Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile, 1987-2000 | 17.2 | 0 | 1 |
| Botox treatment in adductor spasmodic dysphonia: a meta-analysis | 17.2 | 0 | 1 |
| Skin cancer after X-ray treatment for scalp ringworm | 17.2 | 0 | 1 |
| A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial | 17.2 | 0 | 1 |
| Chemoprevention of skin cancer and photoaging | 17.2 | 0 | 1 |
| Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue? | 17.2 | 0 | 1 |
| Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group | 17.2 | 0 | 1 |
| Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer | 17.2 | 0 | 1 |
| John M. Eisenberg Patient Safety Awards. Advocacy: the Lexington Veterans Affairs Medical Center | 17.2 | 0 | 1 |
| Bleeding complications in skin cancer surgery are associated with warfarin but not aspirin therapy | 17.2 | 0 | 1 |
| Prospective study of wound infections in dermatologic surgery in the absence of prophylactic antibiotics | 17.2 | 0 | 1 |
| Inaccuracies in self-reported histories of non-melanoma skin cancer | 17.2 | 0 | 1 |
| Evidence-Based Skin Care Management in Radiation Therapy: Clinical Update | 17.2 | 0 | 1 |
| Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer | 17.2 | 0 | 1 |
| The individualized component face lift: developing a systematic approach to facial rejuvenation | 17.2 | 0 | 1 |
| Making patient safety the centerpiece of medical liability reform | 17.2 | 0 | 1 |
| Relationship between delayed reactions to dermal fillers and biofilms: facts and considerations | 17.2 | 0 | 1 |
| "Natural" ingredients in cosmetic dermatology | 17.2 | 0 | 1 |
| Skin care practices for newborns and infants: review of the clinical evidence for best practices | 17.2 | 0 | 1 |
| A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons | 17.2 | 0 | 1 |
| Evidence-based skin care management in radiation therapy | 17.2 | 0 | 1 |
| The benefits of implementing a new skin care protocol in nursing homes | 17.2 | 0 | 1 |
| The validity of skin care protocols followed by women with breast cancer receiving external radiation | 17.2 | 0 | 1 |
| Long-pulsed Nd:YAG laser treatment of venous lakes: report of a series of 34 cases | 17.2 | 0 | 1 |
| Evidence-Based Skin Care: A Systematic Literature Review and the Development of a Basic Skin Care Algorithm | 17.2 | 0 | 1 |
| Skin Care | 17.2 | 0 | 1 |
| Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers | 17.2 | 0 | 1 |
| Duty Hours, Quality of Care, and Patient Safety: General Surgery Resident Perceptions | 17.2 | 0 | 1 |
| The Effect of Restricting Residents' Duty Hours on Patient Safety, Resident Well-Being, and Resident Education: An Updated Systematic Review | 17.2 | 0 | 1 |
| Decompression in the surgical management of degenerative spondylolisthesis: advantages of a conservative approach in 290 patients | 17.2 | 0 | 1 |
| Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer | 17.2 | 0 | 1 |
| The mandibular septum: anatomical observations of the jowls in aging-implications for facial rejuvenation | 17.2 | 0 | 1 |
| Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer | 17.2 | 0 | 1 |
| The cosmetic treatment of wrinkles | 17.2 | 0 | 1 |
| Global, 3‐dimensional approach to natural rejuvenation: part 1 – recommendations for volume restoration and the periocular area | 17.2 | 0 | 1 |
| Pathophysiology and treatment of decorative tattoos with reference to argon laser treatment | 17.2 | 0 | 1 |
| Does the patient's payer matter in hospital patient safety?: a study of urban hospitals | 17.2 | 0 | 1 |
| Contemporary Mohs surgery applications | 17.2 | 0 | 1 |
| Innovations in natural ingredients and their use in skin care | 17.2 | 0 | 1 |
| Laser treatment of tattoos | 17.2 | 0 | 1 |
| Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin | 17.2 | 0 | 1 |
| Expression of caspase-14 reduces tumorigenicity of skin cancer cells | 17.2 | 0 | 1 |
| Beyond Munchausen syndrome by proxy: identification and treatment of child abuse in a medical setting | 17.2 | 0 | 1 |
| A review of perineal skin care protocols and skin barrier product use | 17.2 | 0 | 1 |
| Carbon dioxide laser treatment of cervical stenosis | 17.2 | 0 | 1 |
| A survey of skin problems and skin care regimens in the elderly | 17.2 | 0 | 1 |
| Hexachlorophene emulsions and antiseptic skin care of newborn infants | 17.2 | 0 | 1 |
| Photodynamic therapy for nonmelanoma skin cancer | 17.2 | 0 | 1 |
| Making health care safer: a critical analysis of patient safety practices | 17.2 | 0 | 1 |
| p53 codon 72 polymorphism and human papillomavirus associated skin cancer | 17.2 | 0 | 1 |
| A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy | 17.2 | 0 | 1 |
| Preventive effect of antioxidant on ultraviolet-induced skin cancer in mice | 17.2 | 0 | 1 |
| Treatment Summaries and Follow-Up Care Instructions for Cancer Survivors: Improving Survivor Self-Efficacy and Health Care Utilization | 17.2 | 0 | 1 |
| A delicate balance: physician work hours, patient safety, and organizational efficiency | 17.2 | 0 | 1 |
| Patient safety and quality of care continue to improve in NHS North West following early implementation of the European Working Time Directive | 17.2 | 0 | 1 |
| Use of Tanning Beds and Incidence of Skin Cancer | 17.2 | 0 | 1 |
| Patient follow-up after participating in a beach-based skin cancer screening program | 17.2 | 0 | 1 |
| Sentinel health event surveillance: skin cancer of the scrotum in New York State | 17.2 | 0 | 1 |
| Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics | 17.2 | 0 | 1 |
| Challenges and remediation for Patient Safety Indicators in the transition to ICD-10-CM | 17.2 | 0 | 1 |
| Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States | 17.2 | 0 | 1 |
| Nurses' shift length and overtime working in 12 European countries: the association with perceived quality of care and patient safety | 17.2 | 0 | 1 |
| Beyond patient safety Flatland | 17.2 | 0 | 1 |
| Fatigue optimization scheduling in graduate medical education: reducing fatigue and improving patient safety | 17.2 | 0 | 1 |
| Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire | 17.2 | 0 | 1 |
| TIG3 Tumor Suppressor-Dependent Organelle Redistribution and Apoptosis in Skin Cancer Cells | 17.2 | 0 | 1 |
| Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer | 17.2 | 0 | 1 |
| Mice with skin-specific DNA repair gene (Ercc1) inactivation are hypersensitive to ultraviolet irradiation-induced skin cancer and show more rapid actinic progression | 17.2 | 0 | 1 |
| Extreme sarcoplasmic reticulum volume loss and compensatory T-tubule remodeling after Serca2 knockout | 17.2 | 0 | 1 |
| Dermatologist-level classification of skin cancer with deep neural networks | 17.2 | 0 | 1 |
| Osmostress-induced cell volume loss delays yeast Hog1 signaling by limiting diffusion processes and by Hog1-specific effects | 17.2 | 0 | 1 |
| Pro-Oxidant Role of Silibinin in DMBA/TPA Induced Skin Cancer: 1H NMR Metabolomic and Biochemical Study | 17.2 | 0 | 1 |
| Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition | 17.2 | 0 | 1 |
| Multimethod study of a large-scale programme to improve patient safety using a harm-free care approach | 17.2 | 0 | 1 |
| Standard-based EHR-enabled applications for clinical research and patient safety: CDISC - IHE QRPH - EHR4CR & SALUS collaboration | 17.2 | 0 | 1 |
| Insights into temporal patterns of hospital patient safety from routinely collected electronic data | 17.2 | 0 | 1 |
| Trends in pharmacy staff´s perception of patient safety in Swedish community pharmacies after re-regulation of conditions | 17.2 | 0 | 1 |
| Skin cancer, irradiation, and sunspots: the solar cycle effect | 17.2 | 0 | 1 |
| What counts? An ethnographic study of infection data reported to a patient safety program | 17.2 | 0 | 1 |
| Dermatology undergraduate skin cancer training: a disconnect between recommendations, clinical exposure and competence | 17.2 | 0 | 1 |
| Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis | 17.2 | 0 | 1 |
| Patient safety and acute care medicine: lessons for the future, insights from the past | 17.2 | 0 | 1 |
| Impact of climate change on skin cancer | 17.2 | 0 | 1 |
| Training a Patient Safety Work Force: The Patient Safety Improvement Corps | 17.2 | 0 | 1 |
| Shedding light on skin cancer | 17.2 | 0 | 1 |
| Organization and representation of patient safety data: current status and issues around generalizability and scalability | 17.2 | 0 | 1 |
| A Case of Lichen Planus Pigmentosus with Facial Dyspigmentation Responsive to Combination Therapy with Chemical Peels and Topical Retinoids | 17.2 | 0 | 1 |
| Number and size of acquired melanocytic nevi and affecting risk factors in cases admitted to the dermatology clinic | 17.2 | 0 | 1 |
| A Split-Face Evaluation to Assess the Efficacy of a Hydrolyzed Roe Cream in the Reduction of Erythema Following Chemical Peel | 17.2 | 0 | 1 |
| Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer | 17.2 | 0 | 1 |
| Comparison of efficacy of chemical peeling with 25% trichloroacetic acid and 0.1% retinoic acid for facial rejuvenation | 17.2 | 0 | 1 |
| Richard Scolyer | 17.2 | 0 | 1 |
| Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans | 17.2 | 0 | 1 |
| A Survey of Skin Problems and Skin Care Regimens in the Elderly | 17.2 | 0 | 1 |
| Mental Health Screening and Follow-up Care in Public High Schools | 17.2 | 0 | 1 |
| Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology | 17.2 | 0 | 1 |
| Anatomy of a patient safety event: a pediatric patient safety taxonomy | 17.2 | 0 | 1 |
| Bolden | 17.2 | 0 | 1 |
| Arsenic Induces p62 Expression to Form a Positive Feedback Loop with Nrf2 in Human Epidermal Keratinocytes: Implications for Preventing Arsenic-Induced Skin Cancer | 17.2 | 0 | 1 |
| Thinning and volume loss of the Arctic Ocean sea ice cover: 2003–2008 | 17.2 | 0 | 1 |
| The impact of long-term follow-up care for childhood cancer survivors: A systematic review | 17.2 | 0 | 1 |
| CO Laser Resurfacing: Recognizing and Minimizing Complications | 17.2 | 0 | 1 |
| Patient safety competence for final-year health professional students: Perceptions of effectiveness of an interprofessional education course | 17.2 | 0 | 1 |
| Patient safety in thoracic surgery and European Society of Thoracic Surgeons checklist | 17.2 | 0 | 1 |
| An Evaluation of Shared Mental Models and Mutual Trust on General Medical Units: Implications for Collaboration, Teamwork, and Patient Safety | 17.2 | 0 | 1 |
| Patient safety skills in primary care: a national survey of GP educators | 17.2 | 0 | 1 |
| Complications of Injectable Fillers, Part 2: Vascular Complications | 17.2 | 0 | 1 |
| Use of simulated pages to prepare medical students for internship and improve patient safety | 17.2 | 0 | 1 |
| Evidence-Based Patient Safety Advisory: Malignant Hyperthermia | 17.2 | 0 | 1 |
| Nurse-physician communication in the long-term care setting: perceived barriers and impact on patient safety | 17.2 | 0 | 1 |
| ACOG Committee Opinion No. 353: Medical emergency preparedness | 17.2 | 0 | 1 |
| Is your patient ready for transport? Developing an ICU patient transport decision scorecard. | 17.2 | 0 | 1 |
| Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India | 17.2 | 0 | 1 |
| Skin cancer concerns particular to women | 17.2 | 0 | 1 |
| Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review | 17.2 | 0 | 1 |
| Paediatric Patient Safety and the Need for Aviation Black Box Thinking to Learn From and Prevent Medication Errors | 17.2 | 0 | 1 |
| Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches | 17.2 | 0 | 1 |
| A systematic review of comorbidity indices used in the nonmelanoma skin cancer population | 17.2 | 0 | 1 |
| Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review | 17.2 | 0 | 1 |
| Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force | 17.2 | 0 | 1 |
| Dermatologic surgery emergencies: Complications caused by systemic reactions, high-energy systems, and trauma | 17.2 | 0 | 1 |
| Dermatologic surgery emergencies: Complications caused by occlusion and blood pressure | 17.2 | 0 | 1 |
| Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis | 17.2 | 0 | 1 |
| Hydrochlorothiazide Use and Skin Cancer: A Mohs Surgeon's Concern | 17.2 | 0 | 1 |
| Validity of the Agency for Health Care Research and Quality Patient Safety Indicators and the Centers for Medicare and Medicaid Hospital-acquired Conditions: A Systematic Review and Meta-Analysis | 17.2 | 0 | 1 |
| Speaking up about traditional and professionalism-related patient safety threats: a national survey of interns and residents | 17.2 | 0 | 1 |
| A Patient Safety Dilemma: Obesity in the Surgical Patient | 17.2 | 0 | 1 |
| Baumann Cosmetic Dermatology | 17.2 | 0 | 1 |
| Michigan Center for Skin Care Research | 17.2 | 0 | 1 |
| Center for Aesthetic Dermatology & Laser Surgery | 17.2 | 0 | 1 |
| New York Laser and Skin Care | 17.2 | 0 | 1 |
| Anesthesia Patient Safety Foundation | 17.2 | 0 | 1 |
| Efficacy of an Intervention to Alter Skin Cancer Risk Behaviors in Young Adults. | 17.2 | 0 | 1 |
| Development of an Internet Intervention to Address Behaviors Associated with Skin Cancer Risk among Young Adults | 17.2 | 0 | 1 |
| Introduction to the STS National Database Series: Outcomes Analysis, Quality Improvement, and Patient Safety | 17.2 | 0 | 1 |
| ‘Speaking up’ about patient safety concerns and unprofessional behaviour among residents: validation of two scales | 17.2 | 0 | 1 |
| Associated Skin Care Specialists | 17.2 | 0 | 1 |
| The intersection of detecting fetal growth restriction and patient safety | 17.2 | 0 | 1 |
| Total body photography for skin cancer screening | 17.2 | 0 | 1 |
| Realistic expectations for safety devices | 17.2 | 0 | 1 |
| Perineal skin care for the incontinent patient | 17.2 | 0 | 1 |
| Tender mercies: providing skin care for an incontinent patient | 17.2 | 0 | 1 |
| Protecting perineal skin integrity. Incontinent patients present unique challenges to successful skin care management. | 17.2 | 0 | 1 |
| E45 cream | 17.2 | 0 | 1 |
| Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer | 17.2 | 0 | 1 |
| Commentary on "the "wide-awake approach" - efficiency and patient safety in carpal tunnel releases" by S. Löw, D. Herold and C. Eingartner | 17.2 | 0 | 1 |
| Using your clinical expertise in nursing education | 17.2 | 0 | 1 |
| Changing the culture of patient safety: leadership's role in health care quality improvement | 17.2 | 0 | 1 |
| Making patient safety the focus: crisis resource management in the undergraduate curriculum | 17.2 | 0 | 1 |
| Immediate steps toward patient safety. | 17.2 | 0 | 1 |
| Incorporating skin care into a facial plastic surgery practice | 17.2 | 0 | 1 |
| Patient safety and risk management | 17.2 | 0 | 1 |
| Computerized decision support systems: improving patient safety in nephrology | 17.2 | 0 | 1 |
| Point-of-care testing, medical error, and patient safety: a 2007 assessment | 17.2 | 0 | 1 |
| Perioperative patient safety: correct patient, correct surgery, correct side--a multifaceted, cross-organizational, interventional study | 17.2 | 0 | 1 |
| Sunlight, ultraviolet radiation, vitamin D and skin cancer: how much sunlight do we need? | 17.2 | 0 | 1 |
| Preoperative evaluation of the body contouring patient: the cornerstone of patient safety | 17.2 | 0 | 1 |
| Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need? | 17.2 | 0 | 1 |
| Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment | 17.2 | 0 | 1 |
| Negotiated or taken-for-granted trust? Explicit and implicit interpretations of trust in a medical setting | 17.2 | 0 | 1 |
| Influence of music and its genres on respiratory rate and pupil diameter variations in cats under general anaesthesia: contribution to promoting patient safety. | 17.2 | 0 | 1 |
| Immunohistochemical detection of p53 protein in basal cell skin cancer after microwave-assisted antigen retrieval | 17.2 | 0 | 1 |
| Personalized music enhances patient perception of the Mohs surgery experience | 17.2 | 0 | 1 |
| Improving Patient Safety in Hospitals through Usage of Cloud Supported Video Surveillance | 17.2 | 0 | 1 |
| Operational units for health risk management (patient safety) | 17.2 | 0 | 1 |
| Skin cancer prevention practices among malignant melanoma survivors: a systematic review | 17.2 | 0 | 1 |
| Continuing the journey to a culture of patient safety: from falls prevention to falls management. | 17.2 | 0 | 1 |
| Leadership and Management in Aesthetic Medicine | 17.2 | 0 | 1 |
| Use of laser technology in orthodontics: hard and soft tissue laser treatments | 17.2 | 0 | 1 |
| Relaxation strategies for patients during dermatologic surgery | 17.2 | 0 | 1 |
| The Laser Test Patch: Principles and Philosophy to Maximize Efficacy and Reduce Complications and Scarring From Laser Treatments. | 17.2 | 0 | 1 |
| Exploring Canadians' and Europeans' Health Care Professionals' Perception of Biological Risks, Patient Safety, and Professionals' Safety Practices | 17.2 | 0 | 1 |
| Skin cancer: the silent pandemic | 17.2 | 0 | 1 |
| Modern prescription theory and application: realistic expectations for speech recognition with hearing AIDS. | 17.2 | 0 | 1 |
| Communication in a medical setting: can standards be improved? | 17.2 | 0 | 1 |
| Music Reduces Patient Anxiety During Mohs Surgery: An Open-Label Randomized Controlled Trial | 17.2 | 0 | 1 |
| Revolutionary advances in sun-protective clothing--an essential step in eliminating skin cancer in our world | 17.2 | 0 | 1 |
| Patient safety in the ambulatory setting. A clinician-based approach | 17.2 | 0 | 1 |
| Use of UV-protective windows and window films to aid in the prevention of skin cancer | 17.2 | 0 | 1 |
| Do you know where your fillers go? An ultrastructural investigation of the lips | 17.2 | 0 | 1 |
| Push for patient safety is nudge for automation. | 17.2 | 0 | 1 |
| Laser treatment for diabetic macular edema in the 21st century | 17.2 | 0 | 1 |
| Realistic expectations for treatment success in Alzheimer's disease | 17.2 | 0 | 1 |
| A tribute to a gifted scholar, Anne Hudson, who has made revolutionary advances in healthcare and patient safety in our nation | 17.2 | 0 | 1 |
| Methodologies used in nursing research designed to improve patient safety. | 17.2 | 0 | 1 |
| Adrenalectomy in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study | 17.2 | 0 | 1 |
| How residents think and make medical decisions: implications for education and patient safety. | 17.2 | 0 | 1 |
| Three-dimensional imaging of normal skin and nonmelanoma skin cancer with cellular resolution using Gabor domain optical coherence microscopy | 17.2 | 0 | 1 |
| Outcomes in threadlift for facial rejuvenation | 17.2 | 0 | 1 |
| A randomized controlled trial of fractional laser therapy and dermabrasion for scar resurfacing | 17.2 | 0 | 1 |
| Efficacy of minimally invasive nonthermal laser-induced optical breakdown technology for skin rejuvenation | 17.2 | 0 | 1 |
| Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries | 17.2 | 0 | 1 |
| Does applying technology throughout the medication use process improve patient safety with antineoplastics? | 17.2 | 0 | 1 |
| Public and professional educational materials on skin cancer | 17.2 | 0 | 1 |
| Partial laryngectomy and radiotherapy for supraglottic cancer: a conservative approach | 17.2 | 0 | 1 |
| Skin cancer associated with ichthyosis: The MAUIE syndrome | 17.2 | 0 | 1 |
| Conservative approach for restoring posterior missing tooth with fiber reinforcement materials: four clinical reports | 17.2 | 0 | 1 |
| Anatomical and molecular imaging of skin cancer | 17.2 | 0 | 1 |
| Mathematical modeling of endovenous laser treatment (ELT). | 17.2 | 0 | 1 |
| Evaluation of the implementation of the alert issued by the UK National Patient Safety Agency on the storage and handling of potassium chloride concentrate solution | 17.2 | 0 | 1 |